Completed Access to Information Requests

About this information

Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).

If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.

*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.

Download datasets of the summaries of completed access to information requests.

Current Search

Report Type

Organization

Disposition

Year

Month

Found 6573 record(s)

Req # A-2024-000336

Adverse Drug Reaction (ADR). Report number: 001081572.

Organization: Health Canada

4 page(s)
October 2024

Req # A-2024-000346

Adverse Drug Reactions (ADRs). Report numbers: E2B_05430367, E2B_05431842, E2B_05752679, E2B_05811247, E2B_05811402.

Organization: Health Canada

290 page(s)
October 2024

Req # A-2024-000369

Adverse Drug Reaction (ADR) for LEUPROLIDE. Report number: 001068464. ADRs for LEUPRORELIN. Report numbers: E2B_04687224, E2B_05850518, E2B_06265053, E2B_06293073, E2B_06306939, E2B_06310733, E2B_06312752, E2B_06312910, E2B_06344084.

Organization: Health Canada

92 page(s)
October 2024

Req # A-2024-000374

Briefing note in the Ministerial Executive Correspondence System (MECS) for the following file: 24-103258-616, The Governor General’s Symposium: Building a Safe and Respectful Digital World.

Organization: Health Canada

6 page(s)
October 2024

Req # A-2024-000390

Adverse Drug Reactions (ADRs) for ARTHRITIS PAIN RELIEF HCD. Report numbers: E2B_07047454, E2B_07049578, E2B_07047381. ADR for Entecavir. Report number: E2B_07075438.

Organization: Health Canada

291 page(s)
October 2024

Req # A-2024-000393

Adverse Drug Reactions (ADRs). Report numbers: E2B_07094507, 001082892, 001086384, 001083517, 001085401, E2B_07101771, E2B_07101770, E2B_07110151, E2B_07106460, E2B_07068509.

Organization: Health Canada

3142 page(s)
October 2024

Req # A-2024-000409

Adverse Drug Reactions (ADRs). Report numbers: 001084101,001085607, 001087651, E2B_07058847, E2B_07059442, E2B_07080694, E2B_07100993, E2B_07003103, E2B_07036439, 001080378.

Organization: Health Canada

166 page(s)
October 2024

Req # A-2024-000439

Adverse Drug Reactions (ADRs). Report numbers: E2B_07181878, E2B_07181880, E2B_07181883, E2B_07181884.

Organization: Health Canada

36 page(s)
October 2024

Req # A-2024-000444

Adverse Drug Reactions (ADRs). Report numbers: E2B_06820613, E2B_06820693, E2B_06820216, E2B_06766936.

Organization: Health Canada

587 page(s)
October 2024

Req # A-2024-000446

Adverse Drug Reactions (ADRs). Report numbers: E2B_04556716, 000987254, E2B_04576390, E2B_04578983, E2B_05185267.

Organization: Health Canada

363 page(s)
October 2024
Date modified: